HK1110790A1 - Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia - Google Patents

Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia

Info

Publication number
HK1110790A1
HK1110790A1 HK08105296.2A HK08105296A HK1110790A1 HK 1110790 A1 HK1110790 A1 HK 1110790A1 HK 08105296 A HK08105296 A HK 08105296A HK 1110790 A1 HK1110790 A1 HK 1110790A1
Authority
HK
Hong Kong
Prior art keywords
amyloid deposits
activated microglia
involving activated
brain
inflammation associated
Prior art date
Application number
HK08105296.2A
Other languages
English (en)
Inventor
Beka Solomon
Orna Goren
Original Assignee
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ramot filed Critical Univ Ramot
Publication of HK1110790A1 publication Critical patent/HK1110790A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/14011—Details ssDNA Bacteriophages
    • C12N2795/14111—Inoviridae
    • C12N2795/14132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/14011—Details ssDNA Bacteriophages
    • C12N2795/14111—Inoviridae
    • C12N2795/14171—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
HK08105296.2A 2005-02-01 2008-05-13 Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia HK1110790A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64838305P 2005-02-01 2005-02-01
PCT/US2006/003291 WO2006083795A1 (en) 2005-02-01 2006-01-31 Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia

Publications (1)

Publication Number Publication Date
HK1110790A1 true HK1110790A1 (en) 2008-07-25

Family

ID=36589064

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08105296.2A HK1110790A1 (en) 2005-02-01 2008-05-13 Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia

Country Status (14)

Country Link
US (3) US7867487B2 (zh)
EP (1) EP1853285B1 (zh)
JP (1) JP5096169B2 (zh)
CN (1) CN101166536B (zh)
AT (1) ATE501723T1 (zh)
CY (1) CY1111455T1 (zh)
DE (1) DE602006020697D1 (zh)
DK (1) DK1853285T3 (zh)
ES (1) ES2363203T3 (zh)
HK (1) HK1110790A1 (zh)
PL (1) PL1853285T3 (zh)
PT (1) PT1853285E (zh)
SI (1) SI1853285T1 (zh)
WO (1) WO2006083795A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101553567A (zh) * 2006-07-21 2009-10-07 台拉维夫大学拉莫特 抑制或治疗与细胞内形成蛋白纤维状内含体或聚集体相关的疾病的方法
US20110182948A1 (en) 2008-05-22 2011-07-28 Beka Solomon Method for treating disease characterized by plaque
MX2011005430A (es) * 2008-11-24 2011-10-28 Univ Ramot Metodo para el tratamiento de la enfermedad de parkinson usando bacetriofago filamentoso.
KR20140051840A (ko) * 2011-03-11 2014-05-02 라모트 앳 텔-아비브 유니버시티 리미티드 신경변성 타우오패씨를 치료하는 방법
WO2013016644A1 (en) 2011-07-27 2013-01-31 Neurophage Pharmaceuticals, Inc. Process for the production of filamentous bacteriophage
TWI547562B (zh) * 2011-08-05 2016-09-01 神經噬菌體製藥股份有限公司 純質絲狀噬菌體及其生產方法
CN104093414A (zh) * 2011-11-29 2014-10-08 神经噬菌体制药股份有限公司 噬菌体的p3作为淀粉样蛋白结合剂的用途
US9655933B2 (en) 2012-03-15 2017-05-23 Ramot At Tel-Aviv University Ltd. Filamentous bacteriophage as an angiogenesis modulator
WO2013138716A1 (en) * 2012-03-15 2013-09-19 Ramot At Tel-Aviv University Ltd. The filamentous bacteriophage as an angiogenesis modulator
DK2906235T3 (en) 2012-10-02 2017-09-25 Proclara Biosciences Inc USE OF P3 OF BACTERIOPHAGIC FUSION PROTEINS AS AMYLOID BINDING AGENTS
EA030389B1 (ru) * 2013-05-28 2018-07-31 Проклара Байосайенсиз, Инк. ПОЛИПЕПТИДЫ, СОДЕРЖАЩИЕ ИЗМЕНЕННУЮ АМИНОКИСЛОТНУЮ ПОСЛЕДОВАТЕЛЬНОСТЬ g3p БАКТЕРИОФАГА С ПОНИЖЕННОЙ ИММУНОГЕННОСТЬЮ
EP3227313B1 (en) 2014-12-03 2022-02-09 Proclara Biosciences, Inc. Polypeptides comprising a modified bacteriophage g3p amino acid sequence lacking a glycosylation signal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE461996T1 (de) * 1999-09-03 2010-04-15 Univ Ramot Verbindungen, zusammensetzungen und verfahren zur behandlung oder vorsorge von alzheimer erkrankung
WO2003059386A2 (en) * 2002-01-18 2003-07-24 Cytos Biotechnology Ag Prion protein carrier-conjugates

Also Published As

Publication number Publication date
EP1853285B1 (en) 2011-03-16
US20110142803A1 (en) 2011-06-16
SI1853285T1 (sl) 2011-07-29
CY1111455T1 (el) 2015-08-05
US8361458B2 (en) 2013-01-29
US20090180991A1 (en) 2009-07-16
PT1853285E (pt) 2011-06-06
JP2008528688A (ja) 2008-07-31
US7867487B2 (en) 2011-01-11
DK1853285T3 (da) 2011-06-27
CN101166536A (zh) 2008-04-23
CN101166536B (zh) 2012-06-27
US20130177533A1 (en) 2013-07-11
JP5096169B2 (ja) 2012-12-12
PL1853285T3 (pl) 2011-08-31
DE602006020697D1 (de) 2011-04-28
WO2006083795A1 (en) 2006-08-10
ATE501723T1 (de) 2011-04-15
ES2363203T3 (es) 2011-07-26
EP1853285A2 (en) 2007-11-14
WO2006083795A8 (en) 2007-03-15

Similar Documents

Publication Publication Date Title
HK1110790A1 (en) Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia
BRPI0907135B8 (pt) uso de um anticorpo antagonista anti-cgrp para a prevenção e/ou tratamento de dor de câncer crônica
MX2010009724A (es) Procedimientos de tratamiento del dolor inflamatorio-.
MX2008006076A (es) Metodos, composiciones y kits para el tratamiento de condiciones medicas.
WO2007084181A3 (en) Bispecific single chain fv antibody molecules and methods of use thereof
TW200716673A (en) Use of TNF &ahr; inhibitor for treatment of erosive polyarthritis
MX2008012023A (es) Metodos para prevenir y tratar enfermedades amiloidogenicas.
MX2009013082A (es) Anticuerpos contra c3b y metodos para la prevencion y el tratamiento de trastornos asociados con el complemento.
EA015654B9 (ru) Антитела против бета-амилоидного пептида
NO20091926L (no) Anti-Notch3-agonist-antistoffer og deres anvendelse ved behandlingen av Notch3-relaterte sykdommer
CL2007002800A1 (es) Anticuerpo monoclonal anti-receptor a de interleucina 17 (il-17ra) o fragmento de union a antigeno del mismo; polinucleotido que lo codifica; metodo de preparacion; y metodo para tratar un trastorno influido por la activacion de il-17ra.
MY147217A (en) Antibody molecules having specificity for human il-06
BRPI0512500A (pt) tratamento ou condições envolvendo desmielinação
WO2006057997A3 (en) Plasmin-inhibitory therapies
GB2475660A (en) Methods and kits for treating cluster headache disorders
MX2009013840A (es) Combinaciones de agentes que disminuyen sap y anticuerpos.
AR107893A1 (es) TERAPIAS COMBINADAS, COMBINACIÓN DE UN INHIBIDOR DE BACE Y UN ANTICUERPO O UN FRAGMENTO DE UNIÓN AL ANTÍGENO PARA EL TRATAMIENTO DE UN TRASTORNO ASOCIADO CON LA ACUMULACIÓN DE b AMILOIDE
TW200507840A (en) Method of treating multiple myeloma
MX2022004270A (es) Inhibidores de aldosa reductasa para el tratamiento de la deficiencia de fosfomannomutasa 2.
WO2005099755A3 (en) Methods of treating autoimmune and inflammatory diseases
WO2009011795A3 (en) Methods for treating stress induced emotional disorders
WO2006122035A3 (en) Method for treating central pain syndrome or for inducing centrally generated pain in an animal model
AR059209A1 (es) Un metodo para tratar una mezcla de aldehido, el uso del aldehido tratado, y un alcohol
WO2007058957A3 (en) Boroproline compound and cytokine combination therapy
WO2004105698A3 (en) Use of phosphatase inhibitors as adjunct therapy for psychiatric disorders

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170131